Millstone Evans Group, LLC Astrazeneca PLC Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Millstone Evans Group, LLC holds 42 shares of AZN stock, worth $3,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42Holding current value
$3,054% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,344Shares Held
478MCall Options Held
5.39MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.57 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.98 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.71 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.68 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.39 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...